{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:28:41Z","timestamp":1759847321128,"version":"3.38.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00063-024-01239-4","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:12:51Z","timestamp":1739477571000},"page":"170-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intensivpflichtige Hauterkrankungen","Dermatological conditions requiring intensive care treatment"],"prefix":"10.1007","volume":"120","author":[{"given":"Christiane","family":"Marks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Widmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Kardaun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"1","key":"1239_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/cc6141","volume":"12","author":"SM George","year":"2008","unstructured":"George\u00a0SM, Harrison\u00a0DA, Welch\u00a0CA, Nolan\u00a0KM, Friedmann\u00a0PS (2008) Dermatological conditions in intensive care: a\u00a0secondary analysis of the intensive care national audit and research center (ICNARC) case mix programme database. Crit Care 12(1):S1","journal-title":"Crit Care"},{"key":"1239_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun\u00a0SH, Sideroff\u00a0A, Valerie-Allanore\u00a0L et\u00a0al (2007) Variability in the clinical pattern of cutaneous side-effetcs of drugs with systemic symptoms: does a\u00a0DRESS syndrome really exist? Br J Dermatol 156:609\u2013611","journal-title":"Br J Dermatol"},{"issue":"48","key":"1239_CR3","first-page":"879","volume":"11","author":"WJ Pichler","year":"2011","unstructured":"Pichler\u00a0WJ, Wendland\u00a0T, Hausmann\u00a0O et\u00a0al (2011) DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). Eine schwere, oft verkannte Medikamentenallergie. Schweiz Med Forum 11(48):879\u2013884","journal-title":"Schweiz Med Forum"},{"issue":"5","key":"1239_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun\u00a0SH, Sekula\u00a0P, Valeyrie-Allanore\u00a0L, Liss\u00a0Y, Chu\u00a0CY, Creamer\u00a0D, Sidoroff\u00a0A, Naldi\u00a0L, Mockenhaupt\u00a0M, Roujeau\u00a0JC, RegiSCAR study group (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169(5):1071\u20131080","journal-title":"Br J Dermatol"},{"key":"1239_CR5","first-page":"67","volume":"145","author":"M Ehaski","year":"2009","unstructured":"Ehaski\u00a0M, Allanore\u00a0L, Musette\u00a0P et\u00a0al (2009) Twelve year analysis for severe cases of drug reaction with eosinophilia and systemic symptoms: a\u00a0cause of unpredictable multiorgan failure. Arch Dermatol 145:67\u201372","journal-title":"Arch Dermatol"},{"key":"1239_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/all.12410","volume":"69","author":"T Ishida","year":"2014","unstructured":"Ishida\u00a0T, Kano\u00a0Y, Mizukawa\u00a0Y, Shiohara\u00a0T (2014) The dynamics of herpesvirus reactivation during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome. Allergy 69:798\u2013805","journal-title":"Allergy"},{"issue":"5","key":"1239_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jaad.2013.11.053","volume":"71","author":"SH Kardaun","year":"2014","unstructured":"Kardaun\u00a0SH, Mockenhaupt\u00a0M, Roujeau\u00a0JC (2014) Comments on: DRESS syndrome. J\u00a0Am Acad Dermatol 71(5):1000\u20131000.e2","journal-title":"J Am Acad Dermatol"},{"issue":"10106","key":"1239_CR8","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","volume":"390","author":"TA Duong","year":"2017","unstructured":"Duong\u00a0TA, Valeyrie-Allanore\u00a0L, Wolkenstein\u00a0P, Chosidow\u00a0O (2017) Severe cutaneous reactions to drugs. Lancet 390(10106):1996\u20132011","journal-title":"Lancet"},{"key":"1239_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00105-018-4153-2","volume":"69","author":"M Mockenhaupt","year":"2018","unstructured":"Mockenhaupt\u00a0M, Paulmann\u00a0M (2018) Schwere Hautreaktionen auf neue Medikamente. Hautarzt 69:278\u2013289","journal-title":"Hautarzt"},{"key":"1239_CR10","doi-asserted-by":"publisher","first-page":"1213889","DOI":"10.3389\/fmed.2023.1213889","volume":"10","author":"EM Marks","year":"2023","unstructured":"Marks\u00a0EM, Botta\u00a0RK, Abe\u00a0R et\u00a0al (2023) Updates in SJS\/TEN: collaboration, innovation, and community. Front Med 10:1213889","journal-title":"Front Med"},{"key":"1239_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant\u00a0A, Mockenhaupt\u00a0M, Naldi\u00a0L, Correia\u00a0O, Schr\u00f6der\u00a0W, Roujeau\u00a0JC (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens Johnson Syndrome, and toxic epidermal necrolysis. Arch Dermatol 138:1019\u20131024","journal-title":"Arch Dermatol"},{"key":"1239_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.jid.5700404","volume":"126","author":"M Grosber","year":"2006","unstructured":"Grosber\u00a0M, Carsin\u00a0H, Leclerc\u00a0F (2006) Epidermal Necrolysis in association with mycoplasma pneumoniae infection. Presented at: meeting on cutaneous adverse drug reactions and ESDR, Paris, France, 7.\u20139.\u00a0September 2006. J\u00a0Invest Dermatol 126:23","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1239_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt\u00a0M, Viboud\u00a0C, Dunant\u00a0A, Naldi\u00a0L, Halevy\u00a0S, Bouwes-Bavinic\u00a0JN, Sidoroff\u00a0A, Schneck\u00a0J, Roujeau\u00a0JC, Flahault\u00a0A (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J\u00a0Invest Dermatol 128(1):35\u201344","journal-title":"J Invest Dermatol"},{"key":"1239_CR14","first-page":"D1739","volume":"161","author":"SH Kardaun","year":"2017","unstructured":"Kardaun\u00a0SH, Huei Liem\u00a0K, Stoutenbeek\u00a0R (2017) Oogafwijkingen bij Stevens-Johnson-syndrom. NTVG 161:D1739","journal-title":"NTVG"},{"issue":"1","key":"1239_CR15","first-page":"5","volume":"8","author":"PD Ghislaine","year":"2002","unstructured":"Ghislaine\u00a0PD, Roujeau\u00a0JC (2002) Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online\u00a0J 8(1):5","journal-title":"Dermatol Online J"},{"issue":"2","key":"1239_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2340\/00015555-0214","volume":"87","author":"SH Kardaun","year":"2007","unstructured":"Kardaun\u00a0SH, Jonkman\u00a0MF (2007) Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis. Acta Derm Venereol 87(2):144\u2013148","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"1239_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann\u00a0S et\u00a0al (2017) Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. JAMA Dermatol 153(6):514\u2013522","journal-title":"JAMA Dermatol"},{"key":"1239_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/archderm.143.6.711","volume":"143","author":"M Ziemer","year":"2007","unstructured":"Ziemer\u00a0M, Wiesend\u00a0CL, Vetter\u00a0R, Weiss\u00a0J, Blaschke\u00a0S, Norgauer\u00a0J, Mockenhaupt\u00a0M (2007) Cutaneous adverse drug reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 143:711\u2013716","journal-title":"Arch Dermatol"},{"key":"1239_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00105-022-05018-0","volume":"73","author":"L Golle","year":"2022","unstructured":"Golle\u00a0L, Michl\u00a0C, Kreft\u00a0B (2022) Bull\u00f6se Arzneimittelreaktion nach Gabe von Pembrolizumab \u2013 2\u00a0Fallberichte. Die Dermatologie 73:959\u2013964","journal-title":"Die Dermatologie"},{"key":"1239_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00105-016-3850-y","volume":"68","author":"M Paulmann","year":"2017","unstructured":"Paulmann\u00a0M, Mockenhaupt\u00a0M (2017) Unfreiwillige Reexposition: Generalisiertes bull\u00f6ses fixes Arzneimittelexanthem bei 2\u00a0\u00e4lteren Patientinnen. Hautarzt 68:59\u201363","journal-title":"Hautarzt"},{"key":"1239_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00105-018-4176-8","volume":"69","author":"M Mockenhaupt","year":"2018","unstructured":"Mockenhaupt\u00a0M (2018) Akute, lebensbedrohliche Medikamentenreaktionen der Haut. Hautarzt 69:364\u2013375","journal-title":"Hautarzt"},{"key":"1239_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00105-020-04593-4","volume":"71","author":"M Ziemer","year":"2020","unstructured":"Ziemer\u00a0M, Dumann\u00a0K (2020) Hautmanifestationen der akuten und chronischen Graft-versus-host-Erkrankung nach allogener Stammzelltransplantation. Hautarzt 71:557\u2013568","journal-title":"Hautarzt"},{"key":"1239_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ajim.22438","volume":"58","author":"FHW Jungbauer","year":"2015","unstructured":"Jungbauer\u00a0FHW, Veenstra-Kyuchukova\u00a0YK, Koeze\u00a0J, KruijtSpanjer, Kardaun\u00a0SH (2015) Management of nosocomial scabies, an outbreak of occupational disease. Am J Ind Med 58:577\u2013582","journal-title":"Am J Ind Med"},{"key":"1239_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.0022-202X.2005.23642.x","volume":"124","author":"M Mockenhaupt","year":"2005","unstructured":"Mockenhaupt\u00a0M, Idzko\u00a0M, Grosber\u00a0M, Sch\u00f6pf\u00a0E, Norgauer\u00a0J (2005) Epidemiology of staphylococcal scalded skin syndrome in Germany. J\u00a0Invest Dermatol 124:700\u2013703","journal-title":"J Invest Dermatol"},{"key":"1239_CR25","first-page":"581","volume-title":"Kinderdermatologie","author":"PH H\u00f6ger","year":"2022","unstructured":"H\u00f6ger\u00a0PH (2022) Erkrankungen durch bakterielle Toxine. In: H\u00f6ger\u00a0PH (Hrsg) Kinderdermatologie. Thieme, Stuttgart, S\u00a0581\u2013582"},{"key":"1239_CR26","first-page":"583","volume-title":"Kinderdermatologie","author":"PH H\u00f6ger","year":"2022","unstructured":"H\u00f6ger\u00a0PH (2022) Erkrankungen durch bakterielle Toxine. In: H\u00f6ger\u00a0PH (Hrsg) Kinderdermatologie. Thieme, Stuttgart, S\u00a0583\u2013584"},{"key":"1239_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cmi.2019.06.031","volume":"26","author":"M Peetermans","year":"2020","unstructured":"Peetermans\u00a0M, de Prost\u00a0N, Eckman\u00a0C, Norrby-Teglund\u00a0A, Skrede\u00a0S, de Waele\u00a0JJ (2020) Necrotizing skin and soft-tissue infections in the intenisve care unit. Clin Microbiol Infect 26:8\u201317","journal-title":"Clin Microbiol Infect"},{"key":"1239_CR28","first-page":"108","volume":"7","author":"M Fischer","year":"2009","unstructured":"Fischer\u00a0M, William\u00a0T, Wohlrab\u00a0J (2009) Dermatosen in der Intensivmedizin. JDDG 7:108\u2013116","journal-title":"JDDG"},{"key":"1239_CR29","first-page":"1163","volume-title":"Braun-Falco s Dermatologie, Venerologie und Allergologie","author":"C Sunderk\u00f6tter","year":"2018","unstructured":"Sunderk\u00f6tter\u00a0C (2018) Vaskulitis und Vaskulopathien. In: Braun-Falco s Dermatologie, Venerologie und Allergologie, Bd. 2. Springer, Berlin, S\u00a01163\u20131164"},{"key":"1239_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJM200108093450603","volume":"345","author":"SN Faust","year":"2001","unstructured":"Faust\u00a0SN, Levin\u00a0M, Harrison\u00a0OB et\u00a0al (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N\u00a0Engl J Med 345:408\u2013416","journal-title":"N Engl J Med"},{"key":"1239_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1056\/NEJMcpc2027093","volume":"384","author":"PK Bendapudi","year":"2021","unstructured":"Bendapudi\u00a0PK, Whalen\u00a0MJ, Lahoud-Rahme\u00a0M, Villalba\u00a0J (2021) Case\u00a07\u201321: A\u00a019-Year-Old Man with Shock, Multiple Organ Failure, and Rash. N\u00a0Engl J Med 384:953\u2013963","journal-title":"N Engl J Med"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01239-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01239-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01239-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:45:41Z","timestamp":1740743141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01239-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01239-4","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"type":"print","value":"2193-6218"},{"type":"electronic","value":"2193-6226"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"C.\u00a0Marks: A.\u00a0Finanzielle Interessen: C.\u00a0Marks gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: angestellte Dermatologin, Universit\u00e4tsklinikum Freiburg, Klinik f\u00fcr Innere Medizin\u00a0I, Hugstetter Str.\u00a053, 79106 Freiburg. E.\u00a0Widmeier: A.\u00a0Finanzielle Interessen: E.\u00a0Widmeier gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellter Internist\/Intensivmediziner, Universit\u00e4tsklinikum Freiburg, Interdisziplin\u00e4re Medizinische Intensivtherapie, Hugstetter Str.\u00a055, 79106 Freiburg. R.\u00a0Marks: A.\u00a0Finanzielle Interessen: R.\u00a0Marks gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: angestellter Internist, Universit\u00e4tsklinikum Freiburg, Klinik f\u00fcr Innere Medizin\u00a0I, Hugstetter Str.\u00a053, 79106 Freiburg. S.\u00a0Kardaun: A.\u00a0Finanzielle Interessen: S.\u00a0Kardaun gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellte Dermatologin, University Medical Center Groningen, Groningen, NL,  Isala-Klinik Meppel (jetzt im Ruhestand) | Mitgliedschaften: Niederl\u00e4ndischer Verein f\u00fcr Dermatologie und Venerologie (NVDV), Internationales Register f\u00fcr schwere arzneimittelinduzierte Hautreaktionen (RegiSCAR; unbezahlt), Independent Researcher (unbezahlt).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}